Minjuvi

tafasitamab · Incyte Biosciences Distribution B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Minjuvi, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: EMA Authorised: Minjuvi (tafasitamab) — Incyte Biosciences Distribution B.V.